Trump-Kennedy Alliance Pushes Public Health Boundaries Despite Vaccination Misinformation
PorAinvest
viernes, 29 de agosto de 2025, 7:52 pm ET1 min de lectura
MRNA--
On Thursday, Trump announced his nomination of Kennedy as the Secretary of Health and Human Services (HHS) of the new US government. The appointment has triggered a sell-off of vaccine companies, with pharmaceutical stocks experiencing significant declines. Moderna's stock price fell by over 5%, Novavax's stock price fell by over 7%, and Pfizer dropped by over 2% [2].
Kennedy's appointment comes after years of advocating for extreme views, opposing vaccines since 2005 and questioning the transparency of public health information in the USA government. His policy proposals are quite radical, and his appointment has caused widespread market unease among investors and health leaders [2].
Kennedy has vowed to determine the cause of rising autism diagnoses, calling it an "epidemic" that "dwarfs the COVID epidemic." He has promised announcements in September, identifying "interventions" that are "certainly causing autism" [1]. However, many experts attribute rising autism diagnoses to improved screening, awareness, and broadened diagnostic criteria, rather than a single new cause [1].
The appointment of Kennedy as HHS Secretary raises concerns about the potential impact on public health initiatives, particularly regarding vaccines. Kennedy's long-standing skepticism towards medical science could jeopardize America's achievements in public health, especially in the time of COVID-19, where vaccines have helped prevent countless infections and deaths [2].
The appointment of Kennedy as HHS Secretary has caused a significant sell-off in vaccine stocks, indicating market uncertainty and concern among investors. The appointment of Kennedy, an anti-vaccine advocate, raises questions about the future direction of public health policy in the United States.
References:
[1] https://www.benzinga.com/news/health-care/25/08/47350698/robert-kennedy-jr-tells-trump-hes-on-course-to-identify-interventions-that-are-certainly-causing-autism-promises-announcements-next-month
[2] https://www.moomoo.com/news/post/38665291/record-tr4cking-news-default
NVAX--
PFE--
Health Secretary Robert F. Kennedy Jr. and President Trump have formed a mutually beneficial alliance, with Kennedy pushing boundaries in public health and science with Trump's support. Their relationship is driven by political calculation and a shared alignment of views, including Kennedy's research into the link between vaccines and autism, a theory widely debunked by medical professionals and studies. Trump benefits from Kennedy's coalition of followers opposed to vaccines and health mandates.
Health Secretary Robert F. Kennedy Jr. and President Trump have formed a mutually beneficial alliance, with Kennedy pushing boundaries in public health and science with Trump's support. Their relationship is driven by political calculation and a shared alignment of views, including Kennedy's research into the link between vaccines and autism, a theory widely debunked by medical professionals and studies. Trump benefits from Kennedy's coalition of followers opposed to vaccines and health mandates.On Thursday, Trump announced his nomination of Kennedy as the Secretary of Health and Human Services (HHS) of the new US government. The appointment has triggered a sell-off of vaccine companies, with pharmaceutical stocks experiencing significant declines. Moderna's stock price fell by over 5%, Novavax's stock price fell by over 7%, and Pfizer dropped by over 2% [2].
Kennedy's appointment comes after years of advocating for extreme views, opposing vaccines since 2005 and questioning the transparency of public health information in the USA government. His policy proposals are quite radical, and his appointment has caused widespread market unease among investors and health leaders [2].
Kennedy has vowed to determine the cause of rising autism diagnoses, calling it an "epidemic" that "dwarfs the COVID epidemic." He has promised announcements in September, identifying "interventions" that are "certainly causing autism" [1]. However, many experts attribute rising autism diagnoses to improved screening, awareness, and broadened diagnostic criteria, rather than a single new cause [1].
The appointment of Kennedy as HHS Secretary raises concerns about the potential impact on public health initiatives, particularly regarding vaccines. Kennedy's long-standing skepticism towards medical science could jeopardize America's achievements in public health, especially in the time of COVID-19, where vaccines have helped prevent countless infections and deaths [2].
The appointment of Kennedy as HHS Secretary has caused a significant sell-off in vaccine stocks, indicating market uncertainty and concern among investors. The appointment of Kennedy, an anti-vaccine advocate, raises questions about the future direction of public health policy in the United States.
References:
[1] https://www.benzinga.com/news/health-care/25/08/47350698/robert-kennedy-jr-tells-trump-hes-on-course-to-identify-interventions-that-are-certainly-causing-autism-promises-announcements-next-month
[2] https://www.moomoo.com/news/post/38665291/record-tr4cking-news-default
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios